Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Glucagon Receptor Protein-VLP (GCGR)

GCGR Origine: Humain Hôte: HEK-293 Cells VLP
N° du produit ABIN7489074
  • Antigène Voir toutes Glucagon Receptor (GCGR) Protéines
    Glucagon Receptor (GCGR)
    Type de proteíne
    VLP
    Origine
    • 4
    • 1
    Humain
    Source
    • 5
    HEK-293 Cells
    Fonction
    Human GCGR / Glucagon receptor Full Length Protein (VLP)
    Séquence
    Ala 26 - Asn 432
    Attributs du produit
    Human GCGR Full Length Protein (VLP) is expressed from human 293 cells (HEK293). It contains AA Ala 26 - Asn 432 (Accession # P47871-1).
    niveau d'endotoxine
    1.0 EU per μg
    Top Product
    Discover our top product GCGR Protéine
  • Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS, Arginine, pH 7.4
    Stock
    -80 °C
    Stockage commentaire
    -70°C
  • Antigène
    Glucagon Receptor (GCGR)
    Autre désignation
    GCGR (GCGR Produits)
    Synonymes
    GCGR Protein, GGR Protein, GR Protein, glucagon receptor Protein, GCGR Protein, Gcgr Protein
    Sujet
    The protein encoded by this gene is a glucagon receptor that is important in controlling blood glucose levels. Defects in this gene are a cause of  type 2 diabetes mellitus (T2DM) . The ever increasing prevalence of type 2 diabetes mellitus in the developed and developing nations calls for the introduction of new and more effective treatments. Glucagon receptor (GCGR) antagonists are highly validated in preclinical models of T2DM and thus have the potential to be developed as a new therapy.
    Pathways
    Carbohydrate Homeostasis, Regulation of Carbohydrate Metabolic Process
Vous êtes ici:
Support technique